Analysis of the Parafoveal Area and Foveal Avascular Zone in Inactive Graves' Ophthalmopathy via Optical Coherence Tomography Angiography: A Meta-Analysis - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Analysis of the Parafoveal Area and Foveal Avascular Zone in Inactive Graves' Ophthalmopathy via Optical Coherence Tomography Angiography: A Meta-Analysis

  • By

  • Sibel Balcı

  • Büşra Yılmaz Tuğan

  • November 26, 2025

Share

Clinical Scorecard: Analysis of the Parafoveal Area and Foveal Avascular Zone in Inactive Graves' Ophthalmopathy via Optical Coherence Tomography Angiography: A Meta-Analysis

At a Glance

CategoryDetail
ConditionGraves' Ophthalmopathy (GO)
Key MechanismsAutoimmune inflammation affecting orbital and periorbital tissues, leading to altered blood flow and hemodynamics.
Target PopulationIndividuals with inactive Graves' ophthalmopathy compared to healthy controls.
Care SettingOphthalmology and endocrinology clinics utilizing OCTA imaging.

Key Highlights

  • GO is characterized by inflammation of orbital tissues and altered blood flow.
  • OCTA provides high-resolution imaging of retinal microvasculature.
  • Meta-analysis included 6 studies comparing inactive GO patients with healthy controls.
  • Findings indicate potential changes in macular OCTA parameters in inactive GO.
  • OCTA sensitivity is notable for early microvascular changes in inflammatory conditions.

Guideline-Based Recommendations

Diagnosis

  • Use OCTA to assess retinal microvasculature in suspected cases of GO.

Management

  • Monitor changes in foveal and parafoveal vessel density and FAZ area in inactive GO patients.

Monitoring & Follow-up

  • Regular OCTA assessments to track microvascular changes over time.

Risks

  • Increased risk of optic nerve damage due to impaired orbital blood flow.

Patient & Prescribing Data

Inactive Graves' ophthalmopathy patients aged 39.3 to 46.1 years.

Focus on managing hyperthyroid symptoms and monitoring ocular health.

Clinical Best Practices

  • Adhere to PRISMA guidelines for systematic reviews and meta-analyses.
  • Utilize OCTA for non-invasive assessment of retinal health in GO patients.
  • Consider demographic factors such as age and gender in treatment planning.

Related Resources & Content

Original Source(s)

Related Content